Reducing antipsychotic medication in people with a learning disability

British Journal of Psychiatry

Volumn 176, Issue JAN., 2000, Pages 42-46

  Ahmed, Zahir ^a,b   Fraser, William ^a   Kerr, Michael P ^a   Kiernan, Chris ^c   Emerson, Eric ^c   Robertson, Janet ^c   Felce, David ^b   Allen, David ^b   Baxter, Helen ^b   Thomas, James ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Welsh Ctr for Learning Disabilities   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; THIORIDAZINE;

ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; DOSE CALCULATION; DRUG USE; DYSKINESIA; HUMAN; LEARNING DISORDER; RANDOMIZED CONTROLLED TRIAL; STEREOTYPY; WITHDRAWAL SYNDROME;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BEHAVIOR; FEMALE; HUMANS; LEARNING DISORDERS; MIDDLE AGED; PRACTICE GUIDELINES; PROSPECTIVE STUDIES;

EID: 0033984232     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.176.1.42     Document Type: Article

References (22)

1. Aman, M. G. & Singh, N. N. (1986) The Aberrant Behavior Checklist. New York: Slosson Educational Publications.
2. Baumeister, A. A., Sevin, J. A. & King, B. H. (1998) Neuroleptics. In Psychotropic Medication and Developmental Disabilities. The International Consensus Handbook (eds S. Reiss & M. G. Aman), pp. 133-150. Columbus, OH: Ohio State University.
3. Branford, D. (1996) Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities. Journal of Intellectual Disability Research, 40, 322-329.
4. Briggs, R. (1989) Monitoring and evaluating psychotropic drug use for persons with mental retardation: a follow up report. American Journal of Mental Retardation, 93, 633-639.
5. Brylewski, J. & Duggan, L. (1998) Antipsychotic Medication for Challenging Behaviour in People with Learning Disability.The Cochrane Library, Issue I, pp. 1-14. Oxford: Update Software.
6. Emerson, E. & Hatton, C. (1994) Moving Out: From Hospital to Community. London: HMSO.
7. _, Alborz, A., Kiernan, C., et al (1997) The HARC Challenging Behaviour Project Report 5: treatment, Management and Service Utilisation. Manchester: Hester Adrian Research Centre, University of Manchester.
8. Fielding, L. T., Murphy, R. J., Reagan, M. W., et al (1980) An assessment programme to reduce drug use with the mentally retarded. Hospital and Community Psychiatry, 31, 771-773.
9. Gualtieri, C. T., Schroeder, S. R., Hicks, R. E., et al (1986) Tardive dyskinesia in young mentally retarded individuals. Archives of General Psychiatry, 43, 335-340.
10. Kalachnik, J. E., Levethal, B. L., James, D. H., et al (1998) Guidelines for the use of psychotropic medication. In Psychotropic Medication and Developmental Disabilities: The International Consensus Handbook (eds S. Reiss & M. G. Amin). Columbus, OH: Ohio State University.
11. Luchins, D. J., Dojka, D. & Hanrahan, P. (1993) Factors associated with reduction in antipsychotic medication dosage in adults with mental retardation. American Journal of Mental Retardation, 98, 165-175.
12. Matson, J. L. (1988) The Psychopathology Instrument For Mentally Retarded Adults. Orland Park, IL: International Diagnostic Systems.
13. McDonnell, A. (1997) Training staff to manage challenging behaviour: an evaluation of a three day training course. British Journal of Developmental Disabilities, 43, 156-61.
14. Molyneaux, P., Emerson, E. & Caine, A. (2000) Prescription of psychotropic medication to people with intellectual disabilities in primary health care settings. Journal of Applied Research in Intellectual Disability, in press.
15. Moss, S., Patel, P., Prosser, H., et al (1993) Psychiatric morbidity in older people with moderate and severe learning disability. I: Development and reliability of the patient interview (PAS-ADD). British Journal of Psychiatry, 163, 471-480.
16. Nihira, K., Leland, H. & Lambert, N. (1993) AAMR Adaptive Behaviour Scale - Residential and Community (2nd edn). Austin, TX: Pro-Ed.
17. Poindexter, A. R. (1989) Psychotropic drug patterns in a large ICF/MR facility. A ten-year experience. American Journal of Mental Retardation, 93, 624-626.
18. Reeves, D. (1994) Calculating Inter-Observer Agreement and Cohen's Kappa on Time-based Observational Data allowing for 'Natural' Measurement Error. Manchester: Hester Adrian Research Centre, University of Manchester.
19. Reiss, S. & Aman, M. G. (1998) Psychotropic Medication and Development Disabilities: The International Consensus Handbook, Columbus, OH: Ohio State University.
20. Sprague, R. L., Kalachnik, J. E. & Shaw, K. M. (1989) Psychometric properties of the Dyskinesia Identification System: Condensed User Scale (DISCUS). Mental Retardation, 27, 141-148.
21. Suen, H. K. & Ary, D. (1989) Analyzing Quantitative Behavioral Observation Data. Hillside, NJ: Laurence Erlbaum.
22. Wressell, S. E., Tyrer, S. P. & Berney, T. P. (1990) Reduction in antipsychotic drug dosage in mentally handicapped patients. A hospital study. British Journal of Psychiatry, 157, 101-106.